Through the new MEERA program, students use virtual welding and 3D printing to explore real-world careers in engineering and ...
Q3 2025 Management View CEO Pravin Dugel described 2025 as "a transformative year for Ocular Therapeutix" and highlighted the advancement of two registrational studies in wet AMD, SOL-1 and SOL-R.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback